Sweden’s drug regulatory authority Medical Products Agency has banned imports from AstraZeneca’s now-closed terbutaline sulphate active pharmaceutical ingredient (API) manufacturing facility in Bangalore, India, after failed validation runs, says rep
| Subscribe To Our Free Newsletter |
